Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Regeneron Pharmaceuticals Inc (REGN)

  • SEC News
  • Jan. 06, 2026, 21:14 UTC
  • 7
  • 1 comments

Director Schenkein David P 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Integer Holdings Corp (ITGR)

  • Business News
  • Jan. 06, 2026, 21:14 UTC
  • 5
  • 1 comments

Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • SEC News
  • Jan. 06, 2026, 21:13 UTC
  • 7
  • 1 comments

Director GOLDSTEIN JOSEPH L 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Mersana Therapeutics (MRSN)

  • SEC News
  • Jan. 06, 2026, 21:12 UTC
  • 7
  • 0 comments

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001306 Size: 30 KB

Comment Full text

Avenue Therapeutics Inc (ATXI)

  • SEC News
  • Jan. 06, 2026, 21:12 UTC
  • 5
  • 0 comments

New Form SCHEDULE 13D/A - AVENUE THERAPEUTICS, INC. Filed: 2026-01-06 AccNo: 0001104659-26-001305 Size: 14 KB

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • SEC News
  • Jan. 06, 2026, 21:12 UTC
  • 5
  • 1 comments

Director RYAN ARTHUR F 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

OPKO HEALTH (OPK)

  • Business News
  • Jan. 06, 2026, 21:12 UTC
  • 4
  • 1 comments

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 5
  • 1 comments

Director COLES N ANTHONY 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Regional Health Properties Inc (RHE$A)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 3
  • 1 comments

(99% Neutral) Regional Health Properties, Inc. (RHE$A) Announces Regulatory Update

Comment Full text

Celsion Corporation (the company was transformed to Imunon (IMNN)) (CLSN)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 3
  • 1 comments

Bragg Kimberly 🟢 acquired 9.1K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000615

Comment Full text

Mersana Therapeutics (MRSN)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 3
  • 0 comments

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001303 Size: 30 KB

Comment Full text

Sight Sciences Inc (SGHT)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 3
  • 1 comments

📋 Badawi Paul (Officer) plans to sell 12K shares of Sight Sciences, Inc. (at $7.48 each, total $89K) Filed: Jan 06, 2026 | ID: 000149

Comment Full text

OPKO Health Inc. (OPK)

  • Business News
  • Jan. 06, 2026, 21:11 UTC
  • 4
  • 1 comments

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Century Therapeutics Inc (IPSC)

  • SEC News
  • Jan. 06, 2026, 21:10 UTC
  • 3
  • 1 comments

Cowan Chad 🔴 sold 1.6K shares of Century Therapeutics, Inc. (IPSC) at $0.99 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Evolent Health Inc (EVH)

  • SEC News
  • Jan. 06, 2026, 21:10 UTC
  • 3
  • 1 comments

Director Smith Jill D. 🟢 acquired 23.1K shares of Evolent Health, Inc. (EVH) Transaction Date: Jan 02, 2026 | Filing ID: 000006

Comment Full text
  • Previous
  • 738
  • 739
  • 740
  • 741
  • 742
  • Next

Search

News categories

  • Technical Exchange News(10969)
  • Event(2441)
  • SEC News(193597)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125910)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin